We assessed the value of the cytomegalovirus (CMV) antigenemia assay for diagnosing primary CMV infection in adults. The CMV antigenemia assay was performed for 40 patients admitted to our unit over a 2-year period with unexplained fever and suspected primary CMV infection. Nine of the 10 patients with primary CMV infection had positive CMV antigenemia assays, and the results were available within 5 hours. All 10 patients had a mononucleosis-like syndrome. All but one of the 30 other patients had negative CMV antigenemia assays. A false-positive result was obtained for a patient with systemic lupus erythematosus. Overall, the CMV antigenemia assay was 90% sensitive and 96% specific for the diagnosis of primary CMV infection. Therefore, the CMV antigenemia assay appears to be a simple, rapid, inexpensive test for the diagnosis of primary CMV infection in hospitalized adults.
Primary cytomegalovirus (CMV) infection is usually asympour unit, and the CMV antigenemia assay was performed on admission because primary CMV infection was suspected. Six tomatic in immunocompetent persons but may manifest as CMV mononucleosis in Ç10% of adults and is characterized patients with HIV infection who enrolled in this study were known to be negative for IgG antibodies to CMV on admission. by fever, liver function test abnormalities, lymphocytosis with atypical lymphocytes, and a usually mild and self-limiting Primary CMV infection was diagnosed by using the following criteria: (1) the presence of a mononucleosis-like syndrome course [1] . However, severe primary CMV infection in immunocompetent individuals can result in multiorgan dysfunction characterized by fever, increased liver enzyme levels (serum alanine aminotransferase level, §40 U/L) and lymphocytosis and is associated with a high mortality rate [2, 3] .
The diagnosis of CMV mononucleosis can be difficult [1] . with atypical lymphocytes on blood smears; (2) the presence of specific IgM antibodies to CMV or a fourfold change in Patients with primary CMV infection are often hospitalized with a wide variety of clinical diagnoses such as prolonged titers of IgG antibodies to CMV; and (3) lack of serological evidence of an ongoing primary Epstein-Barr virus (EBV) infever of unknown origin, and these patients may undergo unnecessary and potentially dangerous diagnostic procedures. fection, as indicated by the absence of antibodies to EBV or by the presence of IgG antibodies to EBV capsid antigen The CMV pp65 antigenemia assay was recently proposed as a reliable and sensitive method for the diagnosis of CMV (EB-VCA) and to Epstein-Barr nuclear antigen (EBNA). disease in immunocompromised patients [4] . The purpose of our study was to assess the value of the CMV antigenemia assay for diagnosing CMV mononucleosis in hospitalized CMV Antigenemia Assay adults, most of whom were immunocompetent.
The Assays for CMV Antibodies serum transaminase levels. The course was self-limiting for nine patients. One HIV-infected patient (patient 7) had a severe IgG antibodies to CMV were detected with an EIA (Enzygprimary CMV infection and recovered only after treatment with nost Anti-CMV/IgG; Behring, Marburg, Germany), according ganciclovir. Examination of a liver biopsy specimen from this to the manufacturer's instructions. Antibody titers were deterpatient with use of specific immunoperoxidase staining for mined by calculation with the alpha-method. A significant in-CMV showed multiple typical CMV inclusions. crease in IgG antibodies to CMV was defined as a fourfold or Blood samples were obtained from these patients 3 -32 days more increase in titer in a pair of samples tested in the same after the onset of fever (median time, 13 days). IgM antibodies run. IgM antibodies to CMV were detected with use of an to CMV were detected during the acute phase of illness in nine EIA (Enzygnost Anti-CMV/IgM; Behring), according to the of 10 patients. For the single patient in whom IgM antibodies manufacturer's instructions.
to CMV were not detected, the titer of IgG antibodies to CMV increased from zero during the acute phase of illness to 4,800
Assays for Antibodies to EBV U/L during convalescence. Five of 10 patients also had fourfold increases in titers of IgG antibodies to CMV. Only single serum Tests for IgG antibodies to EB-VCA and EBNA and for samples were available for analysis from the five remaining IgM antibodies to EB-VCA were performed by using ELISAs patients. Serological data were consistent with a previous EBV (Clin-ELISA VCA IgM, VCA IgG, and EBNA IgG; Bio-Rad, infection (i.e., presence of VCA-specific IgG and antibodies to Ivry sur Seine, France), according to the manufacturer's in-EBNA) for all but one patient. That patient did not have antistructions.
bodies to EBV (VCA-specific IgG and IgM).
Results of CMV antigenemia assays were available within Results 5 hours after blood was obtained from these patients. The assays were positive for nine (90%) of 10 patients; the median
Patients with Primary CMV Infection
number of positive cells was 9 per 200,000 cells examined During the study period, a diagnosis of CMV mononucleosis (range, 1 -650 positive cells). The levels of CMV antigen were was made for 10 patients (table 1) . There were seven men and low (õ20 positive cells) in seven of nine patients. IgM antibodthree women, and the mean age was 38 years (range, 28 -68 ies to CMV were not detected in the patient with a negative years). Seven of the 10 patients had no evidence of immunosup-CMV antigenemia assay. pression. Two patients were infected with HIV, and one was receiving immunosuppressive therapy with azathioprine for
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Crohn's disease. Fever was a constant clinical finding and varied in duration from 3 days to 30 days (median duration, 17 Of the 30 patients without CMV mononucleosis, four were infected with HIV (table 2) . Final diagnoses included a wide days). All patients had atypical lymphocytosis and elevated Rapid laboratory confirmation of primary CMV infection remains a serious obstacle in clinical practice [3] . Serological both IgG and IgM antibodies to CMV. The CMV antigenemia assays were negative for these 29 patients.
tests are usually used for the diagnosis of CMV mononucleosis, but they have a poor sensitivity and specificity [5] . To detect One patient (patient 2, table 2), however, had a high level of CMV antigen along with IgM and IgG antibodies to CMV, a fourfold increase in the titer of IgG antibodies to CMV, preand postinfection sera are needed. Furthermore, the test for suggesting primary CMV infection. Nevertheless, because of an unusual clinical course, with the development of cutaneous IgG antibodies to CMV is positive for õ50% of patients with CMV mononucleosis [1] . It is also a slow procedure that only vasculitis, a diagnosis of systemic lupus erythematosus (SLE) was suspected and confirmed by the presence of antinuclear allows a diagnosis after several weeks of illness. The test for IgM antibodies has a higher sensitivity, but false-positive reand anti-DNA antibodies. When we reviewed the slides, we found that blood leukocytes stained with monoclonal antibodies sults may be obtained for patients with rheumatoid factors or Epstein-Barr virus infection [1] , and IgM antibodies may perto the pp65 CMV protein showed only weak, noncharacteristic staining. We observed similar staining of blood leukocytes sist for up to 1 year after initial infection [1] . Blood leukocyte cultures are considered to be highly specific when we used fluorescein-conjugated goat antibody to mouse alone. Furthermore, repeated CMV shell vial cultures and PCR for the diagnosis of CMV infection in immunocompromised Table 2 . Characteristics of patients without primary cytomegalovirus infection. / 9c48$$mr15 02-05-98 22:35:06 cida UC: CID individuals. Of the 10 patients with CMV mononucleosis reIn our study, only one of the 30 blood samples from patients without primary CMV infection was falsely positive (96% viewed by Cohen and Corey [2] , four had positive CMV blood cultures. However, to our knowledge, no propective study has specificity). This patient had SLE, but such a false-positive result has not been observed for other patients with SLE been performed to assess the value of CMV viremia for the diagnosis of primary CMV infection.
(C. Scieux, personal data). Recent studies indicate that PCR might be the most sensitive Several studies have shown that the CMV antigenemia assay is superior to conventional methods for the diagnosis and specific assay for the early diagnosis of CMV infection [8, 10, 11, 17, 18] . In one study, CMV DNA was detected in of CMV disease in transplant recipients and HIV-infected patients [6 -15] . In these studies, the CMV antigenemia 33 of the 35 initial serum samples from immunocompetent patients with active CMV infection [18] . However, the CMV assay was more sensitive than the shell vial culture and serological assays [6 -16] . CMV antigen detection has an PCR assay is not yet standardized, and its cost is approximately fivefold higher than that of the CMV antigenemia assay. On overall sensitivity of 85% -100% for diagnosing CMV infection in these immunocompromised patients. Moreover, the the contrary, the CMV antigenemia assay is commercially available and does not require sophisticated laboratory equipassay is superior to conventional culture techniques and serological methods. CMV antigenemia usually precedes the ment. We therefore think that CMV antigenemia appears to be the most appropriate biological marker for the rapid diagnosis clinical manifestations of CMV disease, whereas blood cultures become positive and antibody responses appear after of primary CMV infection in hospitalized adults with CMV mononucleosis-like syndromes. Additional studies are needed the onset of CMV disease [8, 10, 17]. The CMV antigenemia assay has other advantages over culture techniques; it is to determine whether our findings may be generalized to outpatients or children. relatively simple to perform and provides results with negligible delay [7] . Furthermore, quantitation of CMV antigenemia may also provide an estimate of the viral load, which antigenemia assay 32 days after the onset of clinical disease.
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